US Patent Issued to Pulsemedica on March 24 for "Spatial light modulation targeting of therapeutic lasers for treatment of ophthalmological conditions" (Canadian Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,553, issued on March 24, was assigned to Pulsemedica Corp. (Edmonton, Canada).

"Spatial light modulation targeting of therapeutic lasers for treatment of ophthalmological conditions" was invented by Nir Katchinskiy (Edmonton, Canada) and Abdulhakem Elezzabi (Edmonton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "A therapeutic laser for use in treating ophthalmological conditions can be modulated by a spatial light modulation device in order to focus the therapeutic laser on a plurality of target locations simultaneously."

The patent was filed on April 26, 2024, under Application No. 18/648,162.

*For further information, including images,...